Ovarian hyperstimulation syndrome: Pre-ovulatory serum concentrations of interleukin-6, interleukin-1 receptor antagonist and tumour necrosis factor-α cannot predict its occurrence

Human Reproduction

Volumn 11, Issue 7, 1996, Pages 1377-1380

  Loret De Mola, J Ricardo ^a,b,c   Baumgardner, Gavin P ^a,b   Goldfarb, James M ^a,b   Friedlander, Miriam A ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Interleukin 1 receptor antagonist; Interleukin 6; Ovarian hyperstimulation syndrome; Ovulation induction; Tumour necrosis factor

Indexed keywords

INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BLOOD LEVEL; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MENSTRUAL CYCLE; NORMAL HUMAN; OVARY DISEASE; OVULATION INDUCTION;

EID: 0029788225     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.humrep.a019403     Document Type: Article

References (33)

1. Adashi, E.Y. (1990) The potential relevance of cytokines to ovarian physiology: the emergent role of resident ovarian cells of the white blood cell series. Endocrinol. Rev., 11, 454-464.
2. Balasch, J., Arroyo, V., Fabregues, F. et al. (1994) Neurohormonal and hemodynamic changes in severe cases of the ovarian hyperstimulation syndrome. Ann. Intern. Med., 121, 27-33.
3. Bergh, P.A. and Navot, D. (1992) Ovarian hyperstimulation syndrome: a review of pathophysiology. J. Assist. Reprod. Genet., 9, 429-438.
4. Best, C.L. and Hill, J.A. (1995) Interleukin-1α and -β modulation of luteinized human granulosa cell oestrogen and progesterone biosynthesis. Hum. Reprod., 10, 3206-3210.
5. Blankstein, J., Mashiach, S. and Lunenfeld, B. (1986) Induction of ovulation with gonadotropins. In Blankstein, J., Mashiach, S. and Lunenfeld, B. (eds), Induction of Ovulation and In Vitro Fertilization. Yearbook Medical Publishers, Chicago, IL.
6. Blankstein, J., Shalev, J., Saadon, T. et al. (1987) Ovarian hyperstimulation syndrome: prediction by size and number of preovulatory ovarian follicles. Fertil. Steril., 47, 597.
7. Casey, L.C., Balk, R.A. and Bone, R.C. (1993) Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann. Intern. Med., 119, 771-778.
8. Dinarello, C.A. (1988) Biology of interleukin-1. FASEB J., 2, 108-115.
9. Erroi, A., Sironi, M., Chiaffarino, F. et al. (1989) IL-1 and IL-6 release by tumor-associated macrophages from human ovarian carcinoma. Int. J. Cancer, 44, 795-801.
10. Espey, L. (1980) Ovulation an inflammatory reaction hypothesis. Biol. Reprod., 22, 73-106.
11. Fong, Y., Tracey, K.J., Moldawer, L.L. et al. (1989) Antibodies to cachectin/tumor necrosis factor reduce interleukin-1β and interleukin-6 appearance during lethal bacteremia. J. Exp. Med., 170, 1627-1633.
12. Friedlander, M.A., Loret de Mola, J.R. and Goldfarb, J.M. (1993a) Elevated levels of interleukin-6 in ascites and serum from women with ovarian hyperstimulation syndrome. Fertil Steril., 60, 826-833.
13. Friedlander, M.A., Hilbert, C.M., Wu, Y.C. and Rich, E.A. (1993b) Role of dialysis modality in response of blood monocytes and peritoneal macrophages to endotoxin stimulation. Am. J. Kidney Dis., 22, 11-23.
14. Gershenwald, J.E., Fong, Y.M., Fahey, T.J. III, et al. (1990) Interleukin-1 receptor blockade attenuates the host inflammatory response. Proc. Natl. Acad. Sci. USA, 87, 4966-4970.
15. Granowitz, E.V., Vannier, E., Poutsiaka, D.D. and Dinarello, C.A. (1992) Effect of interleukin-1 (IL-1) blockade on cytokine synthesis: II. Interleukin-1 receptor antagonist inhibits lipopolysaccharide-induced cytokine synthesis by human monocytes. Blood, 79, 2364-2369.
16. Helle, M., Boeije, L. and Aarden, L.A. (1988) Functional discrimination between IL-6 and IL-1. Eur. J. Immunol., 18, 1535-1540.
17. Hurwitz, A., Loukides, J., Ricciarelli, E. et al. (1992) Human intraovarian interleukin-1 (IL-1) system: highly compartmentalized and hormonally dependent regulation of genes encoding IL-1, its receptor and its receptor antagonist. J. Clin. Invest., 89, 1746-1754.
18. Kahn, S.A., Schmid, K., Hallin, P. et al. (1988) Human testis cytosol and ovarian follicular fluid contains high amounts of interleukin-1 factors(s). Mol. Cell. Endocrinol., 58, 221-230.
19. Kermode, A.G., Churchyard, A. and Carroll, W.M. (1993) Stroke complicating severe ovarian hyperstimulation syndrome. Aust. N.Z. J. Med., 23, 219-220.
20. Loret de Mola, J.R., Flores, J.P., Baumgardner, G., Goldfarb, J. M. and Friedlander, M.A. (1996) Elevated interleukin-6 levels in the ovarian hyperstimulation syndrome; ovarian immunohistochemical localization of interleukin-6 signal. Obstet. Gynecol., 87, 581-587.
21. Loukides, J.A., Loy, R.A., Edwards, R. et al. (1990) Human follicular fluid contains tissue macrophages. J. Clin. Endocrinol. Metab., 71, 1363-1367.
22. Michie, H.R., Spriggs, D.R., Manogue, K.R. et al. (1988) Tumor necrosis factor and endotoxin induce similar metabolic responses in human beings. Surgery, 104, 280-286.
23. Morris, R.S., Paulson, R.J., Sauer, M.V. and Lobo, R.A. (1995) Predictive value of serum oestradiol concentrations and oocyte number in severe ovarian hyperstimulation syndrome. Hum. Reprod., 10, 881-814.
24. Motro, B., Itin, A., Sachs, L. and Keshet, E. (1990) Pattern of interleukin-6 gene expression in vivo suggests a role for this cytokine in angiogenesis. Proc. Natl. Acad. Sci. USA, 87, 3092-3096.
25. Ng, E., Leader, A., Claman, P., Domingo, M. and Spence, J.E.H. (1995) Intravenous albumin does not prevent the development of severe ovarian hyperstimulation syndrome in an in-vitro fertilization programme. Hum. Reprod., 10, 807-810.
26. Niswender, G.D. and Nett, T.M. (1988) The corpus luteum and its control. In Knobil, E. and Neill, J.D. (eds), The Physiology of Reproduction. Raven Press, New York.
27. Orvieto, R., Voliovitch, I., Fishman, P. and Ben-Rafael, Z. (1995) Interleukin-2 and ovarian hyperstimulation syndrome: a pilot study. Hum. Reprod., 10, 24-27.
28. Pride, S.M., Yuen, B.H., Moon, Y.S. and Leung, P.C.S. (1986) Relationship of gonadotropin-releasing hormone, danazol, and prostaglandin blockade to ovarian enlargement and ascites formation of the ovarian hyperstimulation syndrome in the rabbit. Am. J. Obstet. Gynecol., 154, 1155-1160.
29. Roby, K.F., Weed, J., Lyles, L. and Terranova, PF. (1990) Immunological evidence for a human ovarian tumor necrosis factor. J. Clin. Endocrinol. Metabol., 71, 1096-1102.
30. Schenker, J.G. and Weinstein, D. (1978) Ovarian hyperstimulation syndrome: a current survey. Fertil. Steril., 30, 255.
31. Splendiani, G., Mazzarella, V., Tozzo, C., Elli, M. and Casciani, C.U. (1994) Autologous protein reinfusion in severe ovary hyperstimulation syndrome. J. Am. Coll. Surg., 179, 25-28.
32. Vrtovec and Tomazevic, T. (1995) Preventing severe ovarian hyperstimulation syndrome in an in-vitro fertilization/embryo transfer program. Use of follicular aspiration after human chorionic gonadotropin administration. J. Reprod. Med., 40, 37-40.
33. Zolti, M., Merion, R., Shemesh, M. et al. (1990) Granulosa cells as a source and target organ for tumor necrosis factor. FEBS Lett., 261, 253-255.